Original Research
Published on 21 Aug 2017
Development and Characterization of a Camelid Single Domain Antibody–Urease Conjugate That Targets Vascular Endothelial Growth Factor Receptor 2
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2017.00956
- 7,968 views
- 16 citations
